International Spine Study Group Foundation

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, International Spine Study Group Foundation sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).

6 total trials 4 currently recruiting 1 completed upper quartile by trial count

International Spine Study Group Foundation: 6 sponsored US clinical trials, 4 recruiting.

International Spine Study Group Foundation sponsors 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Kyphosis, with 4 trials.

Upper-quartile sponsor footprint

International Spine Study Group Foundation sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

What is open in the International Spine Study Group Foundation pipeline

4 recruiting of 6 indexed (67% open); 1 completed (17%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Kyphosis (4 trials), 4 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

International Spine Study Group Foundation: open-pipeline peers nationwide

Peers matched on 6 registered trials and 67% open enrollment, not the therapeutic-area sidebar.

International Spine Study Group Foundation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 234567 0%20%40%60%80% Total trials Recruiting share International Spine Study Group Foundation23andMeAardvark TherapeuticsAbbisko Therapeutics CoAbGenomics B.V Taiwan BranchABL BioAccelerated Cure Project for Multiple SclerosisAdvanced Reconstructive Surgery AllianceAlexander B Olawaiye, MD
International Spine Study Group Foundation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

International Spine Study Group Foundation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 6 trials (± recruiting share)

Sponsors near 67% open enrollment (± trial volume)

What to do with this International Spine Study Group Foundation page

6 registered trials is a research-attention snapshot, not an endorsement of International Spine Study Group Foundation or any single study.

  • 4 of International Spine Study Group Foundation's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Kyphosis is the condition International Spine Study Group Foundation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Kyphosis trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. International Spine Study Group Foundation pipeline card: 6 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.